Advancing Therapies for Patients

Find a clinical trial

Video

page image
shadow image

Text Size

minus image

plus image

plus image

Print

Print image

Email a Friend

Video

Find a clinical trial

COMBI-d study for patients with metastatic melanoma

 
 

COMBI-d: a phase III study on the combination of dabrafenib and trametinib in patients with metastatic melanoma

Dr Tobias-Hendrik Arkenau describes the results of the COMBI-d study: a randomised, double-blind, phase III study comparing the combination of dabrafenib and trametinib with dabrafenib and placebo as first-line therapy in patients with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma. 

Latest Videos

watch the latest videos.

Learn more

News

news from the industry.

Read more

hero1 image
Sarah Cannon Research UK NHS Ventures
University College London Hospitals
LOC